Privia Health Group (NASDAQ:PRVA) Given New $23.00 Price Target at Barclays

Privia Health Group (NASDAQ:PRVA) had its price objective boosted by Barclays from $21.00 to $23.00 in a research note published on Thursday morning,Benzinga reports. The brokerage currently has an equal weight rating on the stock.

A number of other brokerages have also recently weighed in on PRVA. Truist Financial boosted their price objective on Privia Health Group from $27.00 to $28.00 and gave the company a “buy” rating in a research note on Thursday. Stephens reissued an “overweight” rating and set a $26.00 price objective on shares of Privia Health Group in a research report on Thursday, January 2nd. Macquarie initiated coverage on shares of Privia Health Group in a report on Monday, December 16th. They issued an “outperform” rating and a $25.00 target price for the company. Piper Sandler raised their price target on Privia Health Group from $25.00 to $40.00 and gave the stock an “overweight” rating in a report on Friday, February 28th. Finally, Canaccord Genuity Group upped their price objective on Privia Health Group from $29.00 to $30.00 and gave the company a “buy” rating in a research note on Friday, February 28th. One analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $26.87.

Privia Health Group Trading Up 1.9 %

PRVA stock opened at $24.10 on Thursday. The stock has a market cap of $2.92 billion, a P/E ratio of 241.02, a PEG ratio of 3.47 and a beta of 0.88. Privia Health Group has a twelve month low of $15.92 and a twelve month high of $26.04. The company’s 50 day moving average is $23.76 and its two-hundred day moving average is $21.49.

Insider Activity

In related news, CFO David Mountcastle sold 5,630 shares of the firm’s stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total transaction of $125,999.40. Following the sale, the chief financial officer now owns 179,676 shares in the company, valued at approximately $4,021,148.88. This trade represents a 3.04 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 14.20% of the company’s stock.

Institutional Investors Weigh In On Privia Health Group

A number of institutional investors have recently bought and sold shares of the stock. Riverbridge Partners LLC grew its holdings in shares of Privia Health Group by 19.7% during the 4th quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company’s stock worth $113,868,000 after purchasing an additional 958,418 shares during the period. Loomis Sayles & Co. L P grew its stake in Privia Health Group by 55.0% during the fourth quarter. Loomis Sayles & Co. L P now owns 1,418,234 shares of the company’s stock worth $27,727,000 after buying an additional 503,002 shares during the period. Durable Capital Partners LP increased its position in shares of Privia Health Group by 3.4% in the fourth quarter. Durable Capital Partners LP now owns 11,487,843 shares of the company’s stock worth $224,587,000 after acquiring an additional 378,255 shares in the last quarter. BlackBarn Capital Partners LP lifted its holdings in shares of Privia Health Group by 65.8% during the 4th quarter. BlackBarn Capital Partners LP now owns 663,397 shares of the company’s stock valued at $12,969,000 after acquiring an additional 263,397 shares in the last quarter. Finally, Nuveen Asset Management LLC increased its holdings in Privia Health Group by 19.8% in the 4th quarter. Nuveen Asset Management LLC now owns 1,488,979 shares of the company’s stock valued at $29,110,000 after purchasing an additional 246,393 shares in the last quarter. 94.48% of the stock is currently owned by hedge funds and other institutional investors.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.